A	B	C	D	E	F	G	H	I	J	K
1
2		Name	Indication	Mechanism	Rights	Admin	Approved		Price AUD	308
3		Carimune	CIPD	IVIG					Shares	470.117188	Q222
4		Gamunex	CIPD	IVIG					MC AUD	144796.093904
5		Gardasil	HPV	Vaccine	MRK				Cash USD	10436.4	Q222
6		Hizentra	CIPD	20% IG		subcutaneous			Debt USD	9657.8	Q222
7		Helixate FS	Hemophilia A	rFVIII					EV AUD	144017.493904
8		Helixate NexGen	Hemophilia A	rFVIII					EV USD	96011.66260266666
9		Fluvax	Influenza	Vaccine	Australia
10		Fluad	Influenza	Vaccine
11		Flucelvax	Influenza	Vaccine
12		Foclivia/Focetria	H5N1 Influenza	Vaccine
13		Audenz	H5N1 Influenza	Vaccine
14		Haegarda	HAE	C1 Esterase		subcutaneous
15		Privigen	CIPD	10% IG		IV
16		pdCoag							CEO: Paul Perreault
17		Humate-P							Vifor acquisition
18		Haemate P
19		Biostate
20		Afstyla	Haemophilia A	rFVIII
21		Zemaira/Respreeza	AAT	alpha1-antitrypsin
22		Monoclate-P
23		Idelvion	Haemophilia B	rFIX
24		Beriate P
25							Phase
26		garadacimab	ILD, HAE	FXIIa
27		CSL324	Hidradenitis Suppurativa	G-CSFR mab
28		CSL730		Fc multimer
29		CSL964	GvHD	alpha1-antitrypsin
30		clazakizumab	antibody-mediated rejection	IL-6
31		Etranacogene dezaparvovec	Hemophilia B	rFIX gene therapy
32		Kcentra	Trauma	prothrombin
33		CSL889 (hemopexin)	Sickle Cell Disease
34		trabikibart	Asthma	anti-beta common mab
35		CSL787	Non-CF Bronchiectasis	nebulized IG
36		CSL112	Apolipoprotein A-I	ACS
37		CSL346	DKD	VEGFB mab
38		eblasakimab	Atopic Dermatitis	IL-13R mab
39		mavrilimumab	GCA, RA	GM-CSF
40		aQIVc	Influenza	quadrivalent